These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10499629)

  • 1. Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.
    Kudoh K; Takano M; Koshikawa T; Hirai M; Yoshida S; Mano Y; Yamamoto K; Ishii K; Kita T; Kikuchi Y; Nagata I; Miwa M; Uchida K
    Clin Cancer Res; 1999 Sep; 5(9):2526-31. PubMed ID: 10499629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative genomic hybridization for analysis of chromosomal changes in cisplatin-resistant ovarian cancer].
    Kudoh K; Takano M; Koshikawa T; Yoshida S; Hirai M; Kikuchi Y; Nagata I; Miwa M; Uchida K
    Hum Cell; 2000 Sep; 13(3):109-16. PubMed ID: 11197772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer.
    Takano M; Kudo K; Goto T; Yamamoto K; Kita T; Kikuchi Y
    Hum Cell; 2001 Dec; 14(4):267-71. PubMed ID: 11925927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplicon profiling reveals cytoplasmic overexpression of MUC1 protein as an indicator of resistance to platinum-based chemotherapy in patients with ovarian cancer.
    Takano M; Fujii K; Kita T; Kikuchi Y; Uchida K
    Oncol Rep; 2004 Dec; 12(6):1177-82. PubMed ID: 15547734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM; Jekunen A; Monni O; Joensuu H; Aebi S; Howell SB; Knuutila S
    Genes Chromosomes Cancer; 1997 Apr; 18(4):286-91. PubMed ID: 9087568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism of cisplatin-resistance in ovarian cancer].
    Kikuchi Y
    Hum Cell; 2001 Jun; 14(2):115-33. PubMed ID: 11552292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.
    Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA
    Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
    Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
    Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
    Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
    Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients.
    Song J; Shih IeM; Salani R; Chan DW; Zhang Z
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6842-9. PubMed ID: 17982121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.
    Saldivar JS; Wu X; Follen M; Gershenson D
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S56-71. PubMed ID: 17884153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization].
    Ying HC; Zhang SL; Jiang T; Ouyang L; Lü J
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1009-12. PubMed ID: 17672960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Helou K; Horvath G
    Cancer Genet Cytogenet; 2005 Dec; 163(2):144-50. PubMed ID: 16337857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the cisplatin resistance phenotype in a human ovarian carcinoma cell line segregates with chromosomes 11 and 16.
    Mirakhur B; Parekh HK; Simpkins H
    Cancer Res; 1996 May; 56(10):2256-62. PubMed ID: 8625294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.